1. Home
  2. REAL vs VNDA Comparison

REAL vs VNDA Comparison

Compare REAL & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The RealReal Inc.

REAL

The RealReal Inc.

HOLD

Current Price

$15.56

Market Cap

1.7B

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.84

Market Cap

398.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REAL
VNDA
Founded
2011
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
398.9M
IPO Year
2019
2006

Fundamental Metrics

Financial Performance
Metric
REAL
VNDA
Price
$15.56
$6.84
Analyst Decision
Buy
Strong Buy
Analyst Count
8
3
Target Price
$15.29
$14.00
AVG Volume (30 Days)
2.7M
1.3M
Earning Date
11-10-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$662,789,000.00
$212,074,000.00
Revenue This Year
$17.10
$12.01
Revenue Next Year
$10.96
$21.57
P/E Ratio
N/A
N/A
Revenue Growth
14.30
11.12
52 Week Low
$4.61
$3.81
52 Week High
$16.24
$7.20

Technical Indicators

Market Signals
Indicator
REAL
VNDA
Relative Strength Index (RSI) 63.39 65.87
Support Level $14.02 $6.15
Resistance Level $16.08 $7.20
Average True Range (ATR) 0.75 0.47
MACD 0.06 0.07
Stochastic Oscillator 72.83 83.17

Price Performance

Historical Comparison
REAL
VNDA

About REAL The RealReal Inc.

The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: